|Articles|September 1, 1999

New Treatments for Rheumatoid Arthritis: A Managed Care Perspective
Volume 5
Issue 14 Suppl

The Burden of Rheumatoid Arthritis

Author(s)Frederick Wolfe, MD

Download PDF: The Burden of Rheumatoid Arthritis

Articles in this issue

almost 27 years ago

Article

Participating Faculty

almost 27 years ago

Article

Introduction

almost 27 years ago

Article

Treatment Options for Rheumatoid Arthritis

almost 27 years ago

Article

Managed Care Issues and Rheumatoid Arthritis Treatment

almost 27 years ago

Article

Faculty Question-and-Answer Session

almost 27 years ago

Article

Roundtable I: Practice Patterns for Treating Rheumatoid Arthritis

almost 27 years ago

Article

Roundtable II: Cost Concerns for Rheumatoid Arthritis Treatment

almost 27 years ago

Article

Roundtable III: Impact of Rheumatoid Arthritis on the Healthcare Industry

almost 27 years ago

Article

Selected Abstracts

almost 27 years ago

Article

CME Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

The Burden of Rheumatoid Arthritis

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

Grocery Assistance Benefit Linked to Fewer Diabetes Complications

New York Experts Push for Coordinated Obesity Care Teams

Early Secukinumab Sustains Psoriasis Clearance a Year After Stopping